11/9/2024

Penicillin V Potassium Oral Presentations

Products Affected - Description

- Penicillin V Potassium oral tablet, Rising Pharmaceuticals, 250 mg (400,000 Units), bottle, 1,000 count, NDC 57237-0040-99
- Penicillin V Potassium oral solution, Teva, 250 mg (400,000 Units)/5 mL, 100 mL bottle, NDC 00093-4127-73
- Penicillin V Potassium oral solution, Teva, 250 mg (400,000 Units)/5 mL, 200 mL bottle, NDC 00093-4127-74

Reason for the Shortage

- Hikma has penicillin oral tablets available.
- Rising did not provide a reason for the shortage. Available products are shipping to forecast.
- Sandoz has penicillin oral tablets temporarily unavailable.
- Teva did not provide a reason for the shortage.

Available Products

- Penicillin V Potassium oral tablet, Hikma, 250 mg (400,000 Units), bottle, 100 count, NDC 00143-9837-01
- Penicillin V Potassium oral tablet, Hikma, 250 mg (400,000 Units), bottle, 1,000 count, NDC 00143-9837-10
- Penicillin V Potassium oral tablet, Hikma, 500 mg (800,000 Units), bottle, 100 count, NDC 00143-9836-01
- Penicillin V Potassium oral tablet, Hikma, 500 mg (800,000 Units), bottle, 1,000 count, NDC 00143-9836-10
- Penicillin V Potassium oral tablet, Rising Pharmaceuticals, 250 mg (400,000 Units), bottle, 100 count, NDC 57237-0040-01
- Penicillin V Potassium oral tablet, Rising Pharmaceuticals, 500 mg (800,000 Units), bottle, 100 count, NDC 57237-0041-01
- Penicillin V Potassium oral tablet, Rising Pharmaceuticals, 500 mg (800,000 Units), bottle, 500 count, NDC 57237-0041-05
- Penicillin V Potassium oral tablet, Rising Pharmaceuticals, 500 mg (800,000 Units), bottle, 1,000 count, NDC 57237-0041-99
- Penicillin V Potassium oral solution, Teva, 125 mg (200,000 Units)/5 mL, 100 mL bottle, NDC 00093-4125-73
- Penicillin V Potassium oral solution, Teva, 125 mg (200,000 Units)/5 mL, 200 mL bottle, NDC 00093-4125-74
- Penicillin V Potassium oral tablet, Teva, 250 mg (400,000 Units), bottle, 100 count, NDC 00093-1172-01
- Penicillin V Potassium oral tablet, Teva, 250 mg (400,000 Units), bottle, 1000 count, NDC 00093-1172-10
- Penicillin V Potassium oral tablet, Teva, 500 mg (800,000 Units), bottle, 100 count, NDC 00093-1174-01
- Penicillin V Potassium oral tablet, Teva, 500 mg (800,000 Units), bottle, 1000 count, NDC 00093-1174-10

Estimated Resupply Dates

- Rising has penicillin 250 mg tablets in 1,000 count bottles on intermittent back order and the company is releasing supplies as they become available.
- Teva has penicillin 250 mg/5 mL in 100 mL and 200 mL bottles on intermittent back order and the company is releasing supplies as they become available.

Updated

Updated November 9, 2024 by Elyse MacDonald, PharmD, MS, BCPS. Created May 17, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.